C
Venous thromboembolism
Hemostatic & ThromboticDisease / conditionriskpartially modifiable
20
evidence score
PREVENT status
Not a PREVENT input variable.
Causal support
trial evidence
Score components
lit volume: 4.8meta-analyses: 0trials: 15genetic: 0MR bonus:
References (2)
0 meta-analyses / systematic reviews- Preeclampsia and the Risk of Future Vascular Disease and Mortality: A Review. — Journal of midwifery & women's health 2016 · PMID 27155218
- Homocysteine and cardiovascular disease. — Current atherosclerosis reports 2004 · PMID 15023293
Clinical trials (31)
| NCT | Title | Status | Type | Interventions |
|---|---|---|---|---|
| NCT06440694 | Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis: A Randomized Controlled Pilot Trial | RECRUITING | INTERVENTIONAL | Colchicine 0.5 mg po, Placebo 0.5 mg po |
| NCT06845423 | Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk. An Open-label, Randomized, Controlled Trial Comparing Two Strategies With or Without Pharmacological Thromboprophylaxis | RECRUITING | INTERVENTIONAL | Low molecular weight heparin |
| NCT06873321 | Incidence of Venous Thromboembolism After Lower Limb Revascularization in Patients Receiving Rivaroxaban 2.5 Mg Bid + Aspirin 100 Mg Versus Single Antiplatelet Treatment - a Randomized Clinical Trial | RECRUITING | INTERVENTIONAL | rivaroxaban 2.5 mg bid + aspirin 100 mg, clopidogrel 75 mg od for 3 months followed by aspirin 100 mg od for endovascular procedures or aspirin for open procedures |
| NCT03559114 | PROTEST Trial - PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury, a Double-blind Randomized Controlled Trial | RECRUITING | INTERVENTIONAL | Dalteparin, Saline |
| NCT04662684 | Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial | COMPLETED | INTERVENTIONAL | Rivaroxaban 10 MG |
| NCT02503904 | Tumescent Antibiotic Delivery for Prevention of Surgical Site Infection: A Multicenter Open Label Randomized Clinical Trial | UNKNOWN | INTERVENTIONAL | Concomitant Tumescent Antibiotic Delivery & IV Delivery, Subcutaneous Tumescent Infiltration, cecefazolin and metronidazole (in a dilute solution of tumescent lidocaine, epinephrin and sodium bicarbonate in 0.9% physiologic saline) |
| NCT02379806 | Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Medical Patients Aged 70 Years and Older : a Randomized Placebo-Controlled Study The SYMPTOMS (SYstematic Elderly Medical Patients Thromboprophylaxis : Efficacy on Symptomatic OutcoMeS) Study | COMPLETED | INTERVENTIONAL | Enoxaparin, Placebo |
| NCT02331095 | A Pilot Study of Using Statins in Patients With Acute Venous Thromboembolism (VTE) | TERMINATED | INTERVENTIONAL | Atorvastatin, Anticoagulation Therapy |
| NCT01401725 | Electronic Strategies to Enhance Venous Thromboprophylaxis in Hospitalized Medical Patients | COMPLETED | INTERVENTIONAL | Electronic Order Entry System + CDSS, Electronic Order Entry System Only, Usual Care |
| NCT00895505 | Safety and Efficacy of a D-Dimer-Guided Strategy for Extension of Secondary Prophylaxis of Venous Thromboembolism - a Prospective and Randomized Management Trial | UNKNOWN | INTERVENTIONAL | Phenprocoumon, Warfarin-Natrium |
| NCT00457002 | A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization. | COMPLETED | INTERVENTIONAL | Apixaban, Enoxaparin |
| NCT00437892 | The Effect of Statins on D-dimer Levels in Patients With a Previous Venous Thromboembolic Event | TERMINATED | INTERVENTIONAL | atorvastatin, atorvastatin, diet |
| NCT00541320 | Dose Ranging Trial for the Evaluation of the Safety and Efficacy of GW813893 in the Prophylaxis of Venous Thromboembolism Post Total Knee Replacement Surgery. | WITHDRAWN | INTERVENTIONAL | GW813893 |
| NCT00361894 | RECORD 3 Study: REgulation of Coagulation in ORthopedic Surgery to Prevent DVT and PE; a Controlled., Double-blind, Randomized Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement. | COMPLETED | INTERVENTIONAL | Rivaroxaban (BAY59-7939), Enoxaparin |
| NCT00329628 | RECORD 1 Study: REgulation of Coagulation in ORthopedic Surgery to Prevent DVT and PE, Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement | COMPLETED | INTERVENTIONAL | Rivaroxaban (BAY59-7939), Enoxaparin |
| NCT00119457 | A Multi-Center, Placebo-Controlled Evaluation of the Safety and Efficacy of Three Weeks Extended VTE Prophylaxis With Daily Oral Doses of TTP889 After One Week of Standard Prophylactic Treatment Following Hip Fracture Surgery | COMPLETED | INTERVENTIONAL | TTP889 |
| NCT00152971 | A Phase III, Randomized, Parallel-group, Double-blind, Active Controlled Study to Investigate the Efficacy and Safety of Two Different Dose Regimens (75mg Day 1 Followed by 150 mg Day 2-completion, and 110 mg Day 1 Followed by 220 mg Day 2-completion) of Dabigatran Etexilate Administered Orally (Capsules), Compared to Enoxaparin 30 mg Twice a Day Subcutaneous for 12 - 15 Days in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Knee Replacement Surgery | COMPLETED | INTERVENTIONAL | Dabigatran Dose 1 - day 2 to completion, Dabigatran Dose 1 - day 1, Dabigatran Dose 2 - day 2 to completion |
| NCT00222677 | Aspirin After Six Months or One Year of Oral Anticoagulants for the Prevention of Recurrent Venous Thromboembolism in Patients With Idiopathic Venous Thromboembolism. The WARFASA Study. | UNKNOWN | INTERVENTIONAL | aspirin |
| NCT00398905 | Controlled, Double-Blind, Randomised, Dose-Ranging Study on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement- ODIXa-HIP2 Study BAY 59-7939 | COMPLETED | INTERVENTIONAL | Rivaroxaban (Xarelto, BAY59-7939), Rivaroxaban (Xarelto, BAY59-7939), Rivaroxaban (Xarelto, BAY59-7939) |
| NCT00077805 | An Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin in the Prevention of Venous Thromboembolism in Patients Following Acute Ischemic Stroke | COMPLETED | INTERVENTIONAL | Enoxaparin sodium |
| NCT00655122 | Double-Blind, Placebo-Controlled, Pilot Study, In Medical Patients With Prophylaxis Of Venous Thromboembolism in Primary Care | TERMINATED | INTERVENTIONAL | Dalteparin sodium, Placebo |
| NCT00077753 | A Double-Blind, Placebo-Controlled, Parallel, Multicenter Study on Extended VTE Prophylaxis in Acutely Ill Medical Patients With Prolonged Immobilization | COMPLETED | INTERVENTIONAL | enoxaparin sodium |
| NCT06353373 | Smart Technology Facilitated In-hospital Venous Thromboembolism Prophylaxis Based on Bundled Evidence-based Prevention Strategies: the SmaVTE-BEST Study | UNKNOWN | OBSERVATIONAL | Application of the modified DeVTEcare system |
| NCT05819125 | Comparison of the Risk of Venous Thromboembolism and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis With Enoxaparin | TERMINATED | OBSERVATIONAL | |
| NCT05396157 | Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study of Thrombosis / Bleeding Incidence and Prophylaxis Trends | ACTIVE NOT RECRUITING | OBSERVATIONAL | |
| NCT02742623 | COSIMO Cancer Associated Thrombosis - Patient Reported Outcomes With Rivaroxaban. A Non-interventional Study on Patients Changing to Xarelto® for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer. | COMPLETED | OBSERVATIONAL | Rivaroxaban (Xarelto, BAY 59-7939) |
| NCT02836457 | ELIQUIS (APIXABAN) Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTE | COMPLETED | OBSERVATIONAL | |
| NCT02596230 | Characterization of Patients Following Acute Venous Thromboembolism (VTE) and Safety and Effectiveness of Dabigatran Etexilate (DE) in the Treatment and Secondary Prevention of Acute Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in Comparison to Vitamin K Antagonist (VKA) in Routine Clinical Practice - RE-COVERY DVT/PE | COMPLETED | OBSERVATIONAL | |
| NCT01321788 | Venous Thromboembolism Prophylaxis Post Cesarean Section(PRO-CS-Trial) | UNKNOWN | OBSERVATIONAL | TINZAPARIN, PLACEBO |
| NCT00354796 | The Effect of Reduced Dose of Enoxaparin on the Laboratory and Clinical Outcomes of Treatment With Enoxaparin | UNKNOWN | OBSERVATIONAL | |
| NCT00303407 | Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care | TERMINATED | OBSERVATIONAL | nadroparin |
Genetic associations (0)
None linked.